HeartWare Says Investor Suit Over FDA Regs Is 'Opportunistic'
A shareholder suit against HeartWare International Inc. over a new heart pump product is "opportunistic" and based entirely on implausible inferences drawn from hindsight after a clinical trial failed, the company...To view the full article, register now.
Already a subscriber? Click here to view full article